Plasma coagulation factor levels after AOM treatment
| Group . | Time (h) . | Factor V (%)* . | Factor VII (%)* . | Factor IX (%)* . |
|---|---|---|---|---|
| AOM-15 | 72 | 99.9 ± 9.5 (5) | 134 ± 35 (5) | 133 ± 18 (5) |
| AOM-30 | 48 | 2.4 ± 0.3 (2) | 10.1 ± 6.2 (2) | 29.0 ± 5.0 (2) |
| AOM-50 | 36 | 0.59 ± 0.05 (3) | 1.6 ± 0.2 (3) | 11.3 ± 2.9 (3) |
| Group . | Time (h) . | Factor V (%)* . | Factor VII (%)* . | Factor IX (%)* . |
|---|---|---|---|---|
| AOM-15 | 72 | 99.9 ± 9.5 (5) | 134 ± 35 (5) | 133 ± 18 (5) |
| AOM-30 | 48 | 2.4 ± 0.3 (2) | 10.1 ± 6.2 (2) | 29.0 ± 5.0 (2) |
| AOM-50 | 36 | 0.59 ± 0.05 (3) | 1.6 ± 0.2 (3) | 11.3 ± 2.9 (3) |
Percent procoagulant activity (mean ± sample SD with the number of mice in parenthesis) relative to saline-injected control mice at 72 hours.